ֲý

Skip to Content on ֲý.org
You're location is
All Regions
ֲýr

Nationally Recognized Pediatric Care

Our hospitals are ranked by U.S. News & World Report as among the best in the nation in multi-specialties.

Find Out Why!
Closeup of a person holding a phone using the ֲý app.

We Make Health Care Easy With the ֲý App

Access communications, appointment and symptom tracking and more.

Online Bill Pay

Paying a bill online is easy and secure.

Learn More

Send a Free E-Card

Brighten the day of your loved one staying at one of our hospitals. 

Give It a Try
Young child posing with arms out like he is flying.

KidsHealth Library

Healthy living for parents, kids and teens.

Meet Our Team

Learn more about our physician researchers, clinicians and scientists.

Find a Researcher
# #

    Corinna L. Schultz, MD

    Physician
    Provider Profile

    ֲý Children's Hospital, Delaware 1600 Rockland Road Wilmington, DE 19803

    Biography

    I am a pediatric hematologist dedicated to improving the care of children with classical hematology diseases, especially sickle cell disease and sickle cell trait. Specifically, I am interested in improving the systems of care that surround families of children with blood disorders focusing on how families receive and interpret information about their child's diagnosis and make medical decisions in the context of their child's potentially life-threatening medical condition.

    Fellowship

    • Pediatric Hematology/Oncology - Children's Hospital of Philadelphia, 2014

    Residency

    • Pediatrics - Hasbro Children's Hospital, 2011

    Education

    • MSHP - University of Pennsylvania, 2014
    • M.D. - Thomas Jefferson University - Medical College, 2007

    Board Certifications

    • American Board of Pediatrics/General Pediatrics
    • American Board of Pediatrics/Hematology-Oncology

    • Apixaban versus no anticoagulation for the prevention of venous thromboembolism in children with newly diagnosed acute lymphoblastic leukaemia or lymphoma (PREVAPIX-ALL): a phase 3, open-label, randomised, controlled trial; The Lancet Haematology; (2024).

    • Social Determinants of Health in Cardio-Oncology; JACC: CardioOncology; (2024).

    • Cerebral revascularization surgery reduces cerebrovascular events in children with sickle cell disease and moyamoya syndrome: Results of the stroke in sickle cell revascularization surgery retrospective study; Pediatric Blood & Cancer; (2023).

    • Persistent Disparities in Pediatric Health Care Engagement During the COVID-19 Pandemic; Public Health Reports; (2023).

    • Family‐centered communication in pediatric sickle cell disease; Pediatric Blood & Cancer; (2022).

    • COVID-19 Exposure and Family Impact Scales for Adolescents and Young Adults; Journal of Pediatric Psychology; (2022).

    • Online patient portal use by caregivers in pediatric oncology: Are we widening sociodemographic disparities?; Pediatric Blood & Cancer; (2021).

    • Reproductive intentions in mothers of young children with sickle cell disease; Pediatric Blood & Cancer; (2020).

    • Use of plasma‐derived factor X concentrate in neonates and infants with congenital factor X deficiency; Journal of Thrombosis and Haemostasis; (2020).

    • Hereditary elliptocytosis‐associated alpha‐spectrin mutation p.L155dup as a modifier of sickle cell disease severity; Pediatric Blood & Cancer; (2019).

    • Are on‐line patient portals meeting test result preferences of caregivers of children with cancer? A qualitative exploration; Pediatric Blood & Cancer; (2018).

    • The Influence of Adolescence on Parents' Perspectives of Testing and Discussing Inherited Cancer Predisposition; Journal of Genetic Counseling; (2018).

    • Coexisting Juvenile Dermatomyositis and Sickle Cell Disease: Maintaining a High Degree of Suspicion; The Journal of Pediatrics; (2017).

    • Adherence to prompt fever evaluation in children with sickle cell disease and the health belief model; Pediatric Blood & Cancer; (2015).

    • Influence of the American Society of Hematology Guidelines on the Management of Newly Diagnosed Childhood Immune Thrombocytopenia; JAMA Pediatrics; (2014).

    • Tryptophan Substitution of a Putative D4S6 Gating Hinge Alters Slow Inactivation in Cardiac Sodium Channels; Biophysical Journal; (2005).

    • State-dependent block of voltage-gated Na+ channels by amitriptyline via the local anesthetic receptor and its implication for neuropathic pain; Pain; (2004).

    • Mexiletine block of wild-type and inactivation-deficient human skeletal muscle hNav1.4 Na+channels; The Journal of Physiology; (2004).

    • State-dependent Block of Wild-type and Inactivation-deficient Na+Channels by Flecainide; The Journal of General Physiology; (2003).

    • Tryptophan Scanning of D1S6 and D4S6 C-Termini in Voltage-Gated Sodium Channels; Biophysical Journal; (2003).